17 Mar 2022 08:32
PT Kalbe Farma Tbk (KLBF) stops the development of COVID GX-19 vaccine development, which has entered the 2b/3 clinical testing, due to the COVID-19 status change from a pandemic to an endemic in Indonesia.
Kalbe Farma terminates the COVID GX-19 vaccine development
24 Sep 2021 12:43
PT Kimia Farma (Persero) Tbk (KAEF) scores IDR 53.39 billion in the current year net profit of H1 2021, increasing from the profit reported in the same period in 2020 of IDR 51 billion.
Kimia Farma collects profit of IDR 53.39 billion
13 Aug 2021 06:26
PT Kalbe Farma Tbk (KLBF) had inserted extra capital of KRW 5.58 billion, or equivalent to IDR 71.08 billion, into SL Pogen Inc (SLP).
Kalbe invests IDR 71.08 billion in a Korean company to develop vaccines16 Jul 2021 07:40
The government receives another credit from the Asian Infrastructure Investment Bank (AIIB) of USD 500 million, equivalent to IDR 7.2 trillion, to support vaccine distribution and the COVID-19 pandemic management.
AIIB disburses the third phase of loans of USD 500 million12 Jul 2021 07:55
PT Kalbe Farma Tbk (KLBF) has obtained approval from the National Agency of Drug and Food Control (BPOM) for its clinical testing of 2b/3 stage of the GX-19N COVID-19 vaccine in Indonesia.
Kalbe Farma to conduct clinical testing for GX-19N COVID-19 vaccine in Indonesia
06 Jul 2021 19:13
PT Angkasa Pura I (Persero) would establish vaccination centres for COVID-19 in 15 airports to support the 1 million vaccination per day programme initiated by the government.
Angkasa Pura I to open COVID-19 vaccination centres in 15 airports
23 Mar 2021 06:21
The government has budgeted nearly IDR 700 trillion for national economic recovery in 2021, of which IDR 58 trillion is specifically allocated for vaccination. Meanwhile, taxes will be the basis for the purchase of these vaccines.
Budget allocation for vaccine IDR 58 trillion, with taxes as one of the source19 Feb 2021 10:54
PT Bio Farma (Persero) received a credit facility amounting to IDR 1.5 trillion from PT Bank Danamon Tbk (BDMN) to support the production of the COVID-19 vaccine.
Bio Farma obtains IDR 1.5 trillion credit facility for COVID-19 vaccine production
03 Feb 2021 14:42
Indonesian Ministry of Health estimated Covid-19 vaccine produced by AstraZeneca, a British pharmaceutical company, would arrive in the first quarter of 2021.
AstraZeneca’s vaccine expected to arrive in Indonesia Q1 202103 Feb 2021 07:17
PT Bio Farma (Persero) will complete the production of 11 million doses of COVID-19 vaccine by March 2021.
Bio Farma targets 11 million doses of vaccine to be completed by March 2021